Dr. Gerald Batist honoured by the Canadian Cancer Research Alliance

Dr. Gerald Batist receives the CCRA Award for Exceptional Leadership in Cancer Research from Co-Chairs of the awards ceremony, Dr. Cindy Bell (left) of Genome Canada, and Dr. Sara Urowitz of CCRA and the Canadian Partnership Against Cancer.

Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute (LDI) at the JGH, has received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance.

The Award recognizes his decades-long commitment to accelerating the translation of new discoveries from the research laboratory into clinical benefits for cancer patients.

Dr. Batist has done so by building unique collaborative and multidisciplinary research programs and networks in Quebec, across Canada and internationally, and by addressing major challenges in cancer research and cancer care.

Dr. Rod McInnes, Director of the LDI, praised Dr. Batist as “one of Canada’s most outstanding cancer research leaders. This award is a great recognition that honours not only Dr. Batist, but the Lady Davis Institute and McGill University.”

Dr. Batist is a Professor of Oncology at McGill University and Director of the McGill Centre for Translational Research in Cancer.

His scientific focus is therapeutic resistance in cancer and the development of novel approaches to personalized medicine that offer each patient the most effectively targeted treatments for the active mutations that drive their disease.